Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance (LRA), today announced a pioneering funding ...

In a groundbreaking new study, conducted within the framework of the FWF-funded Cluster of Excellence "Microbiomes drive ...

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral ...

The prevalence of inflammatory bowel disease in U.S. children under 20 is increasing, with over 100,000 affected, revealing ...

Findings on the dACC→PnC circuit show how breathing patterns influence anxiety, paving the way for new therapeutic approaches ...

Dr. Roxana Redis: Retinal organoids have shown remarkable promise, especially in cases where traditional models fall short.

This research evaluates the effects of various gene therapy viral vectors on RPE cells to determine efficacy for therapeutic ...

This research provides a quantitative analysis of the fibroblast-to-myofibroblast transition (FMT), a critical process in ...

Some sequences in the genome cause genes to be switched on or off. Until now, each of these gene switches, or so-called enhancers, was thought to have its own place on the DNA.

Three research institutions in Barcelona have teamed up to launch the world's first Joint Program on Evolutionary Medical Genomics.

After the COVID-19 pandemic struck, online reviews of health care facilities dropped significantly, and they have not yet fully recovered, according to a new analysis led by researchers at the ...

Ins ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has received IND clearance from FDA for ISM5939, a potential best-in-class ...